Geron Corp (GERN)
3.78
+0.12
(+3.28%)
USD |
NASDAQ |
Nov 18, 16:00
3.765
-0.02
(-0.40%)
After-Hours: 20:00
Geron Shareholders Equity (Quarterly): 292.28M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 292.28M |
June 30, 2024 | 306.70M |
March 31, 2024 | 344.87M |
December 31, 2023 | 247.95M |
September 30, 2023 | 290.61M |
June 30, 2023 | 298.43M |
March 31, 2023 | 326.06M |
December 31, 2022 | 80.00M |
September 30, 2022 | 108.17M |
June 30, 2022 | 142.05M |
March 31, 2022 | 97.49M |
December 31, 2021 | 126.42M |
September 30, 2021 | 151.55M |
June 30, 2021 | 176.21M |
March 31, 2021 | 201.16M |
December 31, 2020 | 210.95M |
September 30, 2020 | 232.83M |
June 30, 2020 | 250.68M |
March 31, 2020 | 120.81M |
December 31, 2019 | 135.16M |
September 30, 2019 | 152.39M |
June 30, 2019 | 157.04M |
March 31, 2019 | 169.41M |
December 31, 2018 | 177.73M |
September 30, 2018 | 183.47M |
Date | Value |
---|---|
June 30, 2018 | 178.36M |
March 31, 2018 | 101.13M |
December 31, 2017 | 103.80M |
September 30, 2017 | 108.27M |
June 30, 2017 | 113.01M |
March 31, 2017 | 117.25M |
December 31, 2016 | 122.38M |
September 30, 2016 | 128.91M |
June 30, 2016 | 130.30M |
March 31, 2016 | 136.48M |
December 31, 2015 | 142.13M |
September 30, 2015 | 147.89M |
June 30, 2015 | 118.36M |
March 31, 2015 | 125.18M |
December 31, 2014 | 130.71M |
September 30, 2014 | 137.18M |
June 30, 2014 | 144.58M |
March 31, 2014 | 150.89M |
December 31, 2013 | 59.76M |
September 30, 2013 | 61.88M |
June 30, 2013 | 68.41M |
March 31, 2013 | 76.06M |
December 31, 2012 | 85.65M |
September 30, 2012 | 99.77M |
June 30, 2012 | 114.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
80.00M
Minimum
Dec 2022
344.87M
Maximum
Mar 2024
207.02M
Average
206.05M
Median
Shareholders Equity (Quarterly) Benchmarks
Emergent BioSolutions Inc | 508.40M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 444.95M |
Total Liabilities (Quarterly) | 152.67M |
Debt to Equity Ratio | 0.2868 |
Current Ratio | 2.886 |
Net Debt Paydown Yield | -0.24% |